(Health-NewsWire.Net, September 09, 2016 )
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey Size and Share Published in 2014-08-01 Available for US$ 1995 at Researchmoz.us
Description
To access full report, please visit : http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-turkey-report.html
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Turkey. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.
Turkeys population stood at approximately 76.7 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 1.4%, from 2008. The implementation of the Health Transformation Program (Saglikta Donus, um Programi, HTP) resulted in social security reforms that were aimed at improving the universal health coverage. The available infrastructure for healthcare industries and the high number of healthcare institutions makes Turkey an attractive location for the manufacture and marketing of pharmaceutical products.
The government is trying to increase pharmaceutical R&D in Turkey, and in 2012, it introduced a new investment incentives program that had four basic schemes to increase foreign investment. The pharmaceutical market was worth approximately $12.5 billion, in 2012, and was the sixth-largest pharmaceutical market in Europe. It is set to grow at a CAGR of 7.3% from 2008 to reach $21.5 billion in 2020. The medical device market was valued at approximately $1.9 billion in 2008 and is estimated to grow at a CAGR of 4.7% to reach an estimated $3.3 billion in 2020. These positive growth trends can be primarily attributed to
An increasing elderly population
Universal health coverage
Government initiatives
Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=214389
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Turkey, and includes
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Abdi Ibrahim, Novartis, Sanofi, Bilim and Pfizer; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, F. Hoffmann-La Roche, Essilor International, GE healthcare, and Fresenius Medical Care
Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to
Develop business strategies by understanding the trends shaping and driving Turkeys healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Turkeys healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
Identify, understand, and capitalize on the opportunities and challenges in Turkeys healthcare market
Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=214389
Table of Content
1 Table of Contents 7
1.1 List of Tables 10
1.2 List of Figures 15
2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of the Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 25
3.1.4 Market Segments 26
3.1.5 Overview of Top Five Disease Areas 31
3.1.6 Major Players 34
3.2 Medical Device Market 70
3.2.1 Market Overview 70
3.2.2 Overview of Top Five Segments 72
3.2.3 Diagnostic Market 85
3.2.4 Major Players 87
3.3 Market Drivers and Barriers 119
3.3.1 Drivers 119
3.3.2 Barriers 120
4 Market Access 122
4.1 Reimbursement and Payer Landscape 122
4.1.1 Overview of Healthcare System 122
4.1.2 Reimbursement Process 125
4.1.3 Overview of Insurance Providers 128
4.1.4 Patient Share in Healthcare Spending 132
4.1.5 Price Trend in Healthcare Services 133
4.1.6 Pricing Policies 134
4.2 Regulatory Landscape 136
4.2.1 Overview of Regulatory Agencies 136
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz Mr. Nachiket Ghumare, +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 sales@researchmoz.us <||>rnhttp://www.researchmoz.us/
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|